Brucellosis vaccines market

Q: Which is the leading Type in the market?

RB51 Vaccine is leading type segment in the market. Read more

Brucellosis Vaccines Market, by Type (RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.)), by Application (Cattle, Sheep, Goat and Others (swine, horses, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Jun 2022
CMI5038
149 Pages
Excel & Pdf
Pharmaceutical

Summary

The increasing adoption of strategies such as acquisitions & agreement by key players is expected to drive the market growth over the forecast period. For instance, in September 2020, Hester Biosciences Limited signed an agreement with IVRI (Indian Veterinary Research Institute), an institute under the Indian Council of Agricultural Research (ICAR), to acquire Brucella vaccine technology for developing the Brucella Abortus S19 Delta Pevaccine from IVRI Hester, which manufactures the conventional Brucella Abortus S19 vaccine and supplies it to all the states in India. The S19 Delta Per new generation vaccine technology developed by IVRI will be a step forward towards developing a Brucella vaccine with enhanced immunogenicity and safety, assuring lifelong immunity with a single shot in calf-hood.

The global Brucellosis Vaccines Market is estimated to be valued at US$ 224.64 million in 2022 and expected to exhibit a CAGR of 4.7% over the forecast period (2022-2030)

Figure 1. Global Brucellosis Vaccines Market Share (%) in Terms of Value, By Region, 2022

Increasing investments by key players in market for expansion of brucellosis manufacturing facilities is expected to drive market growth over the forecast period.

For instance, in August 2019, Biovet Private Ltd, an animal health vaccine producing company located in Karnataka, India, announced that it will invest US$ 26,212,600 (Rs 200 crore) for expanding its foot & mouth and brucellosis vaccine manufacturing facilities in Malur, Karnataka, India. This is expected to drive market growth over the forecast period.

Brucellosis Vaccines Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 224.64 Mn
Historical Data for:	2017 to 2021	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	4.7%	2030 Value Projection:	US$ 324.83 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Type: RB51 Vaccine, S19 Vaccine, B19 Vaccine, Others (45/20 vaccine, SR82 vaccine, etc.) By Application: Cattle, Sheep, Goat, Others (swine, horses, etc.)
Companies covered:	Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health, and VETAL Animal Health Products Inc.
Growth Drivers:	Increasing prevalence of brucellosis Increasing government initiatives
Restraints & Challenges:	Drawbacks associated with brucellosis vaccines

Figure 2. Global Brucellosis Vaccines Market Share (%), by Type, 2022

Global Brucellosis Vaccines Market: Restraint

Drawbacks associated with use of brucellosis vaccines is expected to act as a restraint for the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the Journal of Veterinary Science, an international, peer-reviewed, open-access journal of veterinary medicine, in August 2017, currently available brucellosis vaccines exhibit one or more major drawbacks such as residual virulence and serodiagnostic interference. Moreover, according to an article published by the journal Veterinary Research, an open access journal that publishes high quality novel research and review articles, in July 2015, although the available vaccines are effective in controlling brucellosis, they have numerous drawbacks such as interference with diagnostic tests, pathogenicity for humans, and potential to cause abortion in pregnant animals, among others.

Key Players

Major players operating in the global brucellosis vaccines market include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health, and VETAL Animal Health Products Inc.

Table of Content

Table of Contents

*Browse 26 market data tables and 28 figures on "Global Brucellosis Vaccines Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global Brucellosis Vaccines Market during the forecast period (2022-2030)?

The global brucellosis vaccines market size is estimated to be valued at US$ 224.64 Mn in 2022 and expected to exhibit a CAGR of 4.7% between 2022 and 2030.

What are the major factors driving the market growth?

Increasing prevalence of brucellosis and increasing government initiatives are expected to drive market growth over the forecast period.

Which is the leading Type in the market?

RB51 Vaccine is leading type segment in the market.

Which region holds the largest market share in the market?

North America holds the largest market share in the market.

What are the key factors hampering the growth of the market?

Major factors hampering the market growth include drawbacks associated with brucellosis vaccines.

Which are the major players operating in the market?

Major players operating in the market include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health, and VETAL Animal Health Products Inc.